18R

3-{1-[(3R)-1-acryloylpiperidin-3-yl]-4-amino-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-N-(3-tert-butylphenyl)benzamide

Created:	2012-11-02
Last modified:	2012-11-09

Find Related PDB Entry
1 entries where 18R is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	72
Chiral Atom Count	1
Bond Count	76
Aromatic Bond Count	22

2D diagram of 18R

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	3-{1-[(3R)-1-acryloylpiperidin-3-yl]-4-amino-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-N-(3-tert-butylphenyl)benzamide
Systematic Name (OpenEye OEToolkits)	3-[4-azanyl-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(3-tert-butylphenyl)benzamide
Formula	C₃₀ H₃₃ N₇ O₂
Molecular Weight	523.629
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(Nc1cc(ccc1)C(C)(C)C)c5cccc(c3nn(c2ncnc(c23)N)C4CCCN(C(=O)/C=C)C4)c5
SMILES	CACTVS	3.370	CC(C)(C)c1cccc(NC(=O)c2cccc(c2)c3nn([CH]4CCCN(C4)C(=O)C=C)c5ncnc(N)c35)c1
SMILES	OpenEye OEToolkits	1.7.6	CC(C)(C)c1cccc(c1)NC(=O)c2cccc(c2)c3c4c(ncnc4n(n3)C5CCCN(C5)C(=O)C=C)N
Canonical SMILES	CACTVS	3.370	CC(C)(C)c1cccc(NC(=O)c2cccc(c2)c3nn([C@@H]4CCCN(C4)C(=O)C=C)c5ncnc(N)c35)c1
Canonical SMILES	OpenEye OEToolkits	1.7.6	CC(C)(C)c1cccc(c1)NC(=O)c2cccc(c2)c3c4c(ncnc4n(n3)[C@@H]5CCCN(C5)C(=O)C=C)N
InChI	InChI	1.03	InChI=1S/C30H33N7O2/c1-5-24(38)36-14-8-13-23(17-36)37-28-25(27(31)32-18-33-28)26(35-37)19-9-6-10-20(15-19)29(39)34-22-12-7-11-21(16-22)30(2,3)4/h5-7,9-12,15-16,18,23H,1,8,13-14,17H2,2-4H3,(H,34,39)(H2,31,32,33)/t23-/m1/s1
InChIKey	InChI	1.03	RMAUIYTVKFMOGP-HSZRJFAPSA-N

Related Resource References

Resource Name	Reference
PubChem	72200985

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.